Clinical Trials Directory

Trials / Completed

CompletedNCT04084639

Mycoprotein Consumption and Glucose Absorption

To Determine the Effects of Mycoprotein Consumption on Glucose Absorption in Healthy Participants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University of Exeter · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Previous research has demonstrated that the food found in Quorn 'Mycoprotein' can lower the blood glucose response to a meal, which may be an important finding for the management of type 2 diabetes. However, it has never been investigated how this lower response occurs, and whether there is dose-dependent response with mycoprotein. The present study will include 12 healthy young adults, who will visit the laboratory for 3 test days, with each day lasting 9 hours. On each visit, separated by a washout period of at least 2 weeks, participants will ingest either a control drink with no mycoprotein, a drink containing 20g mycoprotein or a drink containing 40g mycoprotein. By intravenously infusing labelled glucose during each visit in combination with repeated blood sampling, investigators will determine if the lower blood glucose after mycoprotein ingestion is due to reduced glucose absorption from the gut or increased uptake into body tissues.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMycoprotein IngestionIngestion of various doses of mycoprotein compared to placebo control

Timeline

Start date
2019-08-28
Primary completion
2019-10-16
Completion
2019-10-16
First posted
2019-09-10
Last updated
2019-11-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04084639. Inclusion in this directory is not an endorsement.